You just read:

Avicanna (TSX: AVCN) Enters an Exclusive Research Agreement with the University of Guelph for Proprietary Cannabinoid-based Products and Formulations to Treat Psychiatric Disorders

News provided by

Avicanna Inc.

Sep 13, 2019, 07:55 ET